ACXP Return on Tangible Equity | Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. (ACXP) Return on Tangible Equity

2026-06-30: Return Tang Equity -92.08%.
2026-03-31: Return Tang Equity -106.92%.
2025-12-31: Return Tang Equity -151.21%.
2025-09-30: Return Tang Equity -252.13%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-92.08%
2026-03-31	-106.92%
2025-12-31	-151.21%
2025-09-30	-252.13%
2025-06-30	-280.37%
2025-03-31	-513.73%
2024-12-31	-2292.74%
2024-09-30	-616.96%
2024-06-30	-488.09%
2024-03-31	-267.61%
2023-12-31	-312.38%
2023-09-30	-323.37%
2023-06-30	-211.54%
2023-03-31	-232.06%
2022-12-31	-165.31%
2022-09-30	-117.37%
2022-06-30	-142.96%
2022-03-31	-130.44%
2021-12-31	-102.72%
2021-09-30	-78.54%
2021-06-30	-50.81%
2021-03-31	-194.05%
2020-12-31	-170.27%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-151.21%
2024-12-31	-2292.74%
2023-12-31	-312.38%
2022-12-31	-165.31%
2021-12-31	-102.72%
2020-12-31	-170.27%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
InMed Pharmaceuticals Inc. (INM)		$0.008B	-0.65
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Pulmatrix, Inc. (PULM)	United States	$0.006B